DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Creutzig U, Zimmermann M, Bourquin JP et al.
Second induction with high-dose cytarabine and mitoxantrone: different impact on pediatric AML patients with t(8;21) and with inv(16).
Blood 2011;
118: 5409-5415
We do not assume any responsibility for the contents of the web pages of other providers.